ArticleBreast (Edinburgh, Scotland)2023

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.

Arlene Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.